Somatix regulatory update

The Alameda, Calif., company said that the Whitehead Institute received U.S. Patent No. 5,449,614 covering the use of a packaging cell line to produce non-replicating retroviral vectors for human gene therapy. The technology is exclusively licensed to SOMA. ...